Showing results (781-790 of 8,885) with videos related to

Sort By:
Pageof 889
European Urology|January 1, 1987
Renal hamartoma associated with renal cell (Grawitz) tumor: another indication that Grawitz tumors are carcinosarcomasJ J Govaerts, J C van Gooswilligen, G P Vooys, et al.
European Urology|January 2, 2017
Clinical Outcomes of Patients with Histologic Variants of Urothelial Cancer Treated with Trimodality Bladder-sparing TherapyRoss E Krasnow, Michael Drumm, Hannah J Roberts, et al.
European Urology|January 14, 2017
Adjuvant Treatment of High-risk Renal Cell Carcinoma: Leaving the Desert?Nils Kroeger, Arnulf Stenzl, Martin Burchardt, et al.
European Urology|November 6, 2016
Cytoreductive Nephrectomy in the Tyrosine Kinase Inhibitor Era: A Question That May Never Be AnsweredGrant D Stewart, Michael Aitchison, Axel Bex, et al.
European Urology|November 7, 2016
Quantifying the Transition from Active Surveillance to Watchful Waiting Among Men with Very Low-risk Prostate CancerMieke Van Hemelrijck, Hans Garmo, Lars Lindhagen, et al.
European Urology|October 19, 2016
Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell CarcinomaJames J Hsieh, David Chen, Patricia I Wang, et al.
European Urology|October 1, 2016
Systematic Review of the Performance of Noninvasive Tests in Diagnosing Bladder Outlet Obstruction in Men with Lower Urinary Tract SymptomsSachin Malde, Arjun K Nambiar, Roland Umbach, et al.
European Urology|January 1, 1991
Complete androgen deprivation prior to radical prostatectomy in patients with stage T3 cancer of the prostateJ Flamm, M Fischer, W Höltl, et al.
European Urology|January 22, 2017
A Functional Genetic Screen Identifies the Phosphoinositide 3-kinase Pathway as a Determinant of Resistance to Fibroblast Growth Factor Receptor Inhibitors in FGFR Mutant Urothelial Cell CarcinomaLiqin Wang, Tonći Šuštić, Rodrigo Leite de Oliveira, et al.
European Urology|February 16, 2017
Persistence and Adherence with Mirabegron versus Antimuscarinic Agents in Patients with Overactive Bladder: A Retrospective Observational Study in UK Clinical PracticeChristopher R Chapple, Jameel Nazir, Zalmai Hakimi, et al.
Pageof 889